JW Pharmaceutical Corporation (KRX:001060)

Market Cap	508.44B
Revenue (ttm)	719.38B
Net Income (ttm)	65.04B
Shares Out	23.11M
EPS (ttm)	2,788.47
PE Ratio	7.85
Forward PE	6.54
Dividend	450.00 (2.05%)
Ex-Dividend Date	Dec 27, 2024

Volume	24,492
Average Volume	30,891
Open	21,850
Previous Close	22,000
Day's Range	21,700 - 21,950
52-Week Range	19,600 - 34,950
Beta	1.04
RSI	50.52
Earnings Date	May 15, 2025

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 1,064
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001060

Financial Performance

In 2024, JW Pharmaceutical's revenue was 719.38 billion, a decrease of -3.89% compared to the previous year's 748.53 billion. Earnings were 65.04 billion, an increase of 75.75%.